Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Klose, H; Opitz, C; Bremer, H; Ewert, R; Bonderman, D; Rosenkranz, S; Seeger, W; Schmeißer, A; Harbaum, L; Buerke, M; Ghofrani, HA; Borst, MM; Leuchte, HH; Lange, TJ; Behr, J; Ulrich, S; Lang, I; Olschewski, H; Gall, H; Kabitz, HJ; Kleber, FX; Held, M; Hoeper, MM; Grünig, E.
Targeted therapy of pulmonary arterial hypertension (PAH)].
DEUT MED WOCHENSCHR. 2014; 139 Suppl 4(9): S142-S150.
Doi: 10.1055/s-0034-1387489
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Olschewski Horst
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
- Adult -
- Antihypertensive Agents - adverse effects Antihypertensive Agents - therapeutic use
- Combined Modality Therapy -
- Cooperative Behavior -
- Drug Approval -
- Drug Therapy, Combination -
- Endothelin Receptor Antagonists - adverse effects Endothelin Receptor Antagonists - therapeutic use
- Evidence-Based Medicine -
- Humans -
- Hypertension, Pulmonary - diagnosis Hypertension, Pulmonary - drug therapy Hypertension, Pulmonary - mortality
- Interdisciplinary Communication -
- Molecular Targeted Therapy - methods
- Phosphodiesterase 5 Inhibitors - adverse effects Phosphodiesterase 5 Inhibitors - therapeutic use
- Pyrazoles - adverse effects Pyrazoles - therapeutic use
- Pyrimidines - adverse effects Pyrimidines - therapeutic use
- Randomized Controlled Trials as Topic -
- Survival Rate -
- Treatment Outcome -